In this webcast, experts will discuss the history of DAPT duration for patients undergoing PCI with DES, review the contemporary data supporting shorter term DAPT duration for patients with HBR, translate the data into clinical practice and identify what gaps still exist, including what is the best monotherapy agent once DAPT has been terminated.
